Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |